Literature DB >> 25623249

Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis--yes.

Gavin Giovannoni.   

Abstract

Entities:  

Keywords:  MRI; Multiple sclerosis; T2-lesions; outcome measure

Mesh：

Substances：

Year:  2015        PMID： 25623249     DOI： 10.1177/1352458514566261

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score.

Authors:  Francisco Carlos Pérez-Miralles; Jordi Río; Deborah Pareto; Àngela Vidal-Jordana; Cristina Auger; Georgina Arrambide; Joaquín Castilló; Mar Tintoré; Àlex Rovira; Xavier Montalban; Jaume Sastre-Garriga
Journal:  Neuroradiology       Date:  2020-11-25       Impact factor: 2.804

Review 2.  Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions.

Authors:  Andrew L Smith; Jeffrey A Cohen; Le H Hua
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.